Sitavig

Chickenpox, Encephalitis, Herpes Simplex, Neutropenia + 18 more

Treatment

20 Active Studies for Sitavig

Treatment for

Chickenpox

What is Sitavig

AcyclovirThe Generic name of this drug

Treatment SummaryAcyclovir is an antiviral drug used to treat different types of herpes, including herpes simplex, Varicella zoster, herpes zoster, herpes labialis, and acute herpetic keratitis. It is often the first treatment prescribed for these viruses and can be given to children as young as 6 years old. Acyclovir was approved by the FDA in 1982.

Zoviraxis the brand name

image of different drug pills on a surface

Sitavig Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Zovirax

Acyclovir

1982

496

Effectiveness

How Sitavig Affects PatientsAcyclovir is a drug that stops the spread of viruses associated with herpes, such as cold sores. It works by blocking the DNA replication of the virus. Acyclovir is usually safe to take, even in large doses, and so it has a wide range of doses it can be taken at.

How Sitavig works in the bodyAcyclovir works by interfering with the virus's ability to reproduce. When a virus infects a cell, it uses an enzyme called thymidine kinase to turn acyclovir into a form called acyclovir monophosphate. This form is then converted to a diphosphate form by guanylate kinase. The diphosphate form is then converted to the active form, acyclovir triphosphate, by enzymes like pyruvate kinase. Acyclovir triphosphate has a high affinity for the virus's DNA polymerase, and

When to interrupt dosage

The prescribed dosage of Sitavig is contingent upon the diagnosed condition, including Cytomegalovirus Infections, grave Genital herpes and Herpes simplex type I resurgence. The measure of dosage is contingent on the technique of delivery (e.g. Cream - Topical or Injection, powder, lyophilized, for solution - Intravenous) as detailed in the table below.

Condition

Dosage

Administration

VZV re-activation

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Herpes Labialis

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

prophylaxis of VZV re-activation

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Herpes simplex type I reactivation

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Cytomegalovirus Infections

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Keratitis, Herpetic

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Recurrent Herpes Labialis

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Bone Marrow Transplant

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

severe Genital herpes

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

prophylaxis of HSV re-activation

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Genital Herpes

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Neutropenia

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Genital Herpes

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Chickenpox

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Immunocompromised

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Encephalitis, Herpes Simplex

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Herpes Simplex Infections

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Shingles

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Bell's Palsy

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Communicable Diseases

200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL

, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical

Warnings

Sitavig has one contraindication, thus it should not be blended with the ailments enumerated in the following table.Sitavig Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Acyclovir may interact with Pulse Frequency

There are 20 known major drug interactions with Sitavig.

Common Sitavig Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The excretion of Abemaciclib can be decreased when combined with Acyclovir.

Neomycin

Major

The risk or severity of nephrotoxicity can be increased when Acyclovir is combined with Neomycin.

Procainamide

Major

The excretion of Procainamide can be decreased when combined with Acyclovir.

Tenofovir

Major

Acyclovir may increase the nephrotoxic activities of Tenofovir.

Tenofovir alafenamide

Major

Acyclovir may increase the nephrotoxic activities of Tenofovir alafenamide.

Sitavig Toxicity & Overdose RiskOverdosing on Cyclosporin can cause agitation, loss of consciousness, seizures, and excessive sleepiness. These effects are more likely to occur in those who have not been monitored for fluid levels or kidney function. Treatment for Cyclosporin overdose should involve supportive care and addressing the symptoms.

image of a doctor in a lab doing drug, clinical research

Sitavig Novel Uses: Which Conditions Have a Clinical Trial Featuring Sitavig?

34 clinical studies are presently assessing the potential of Sitavig to prophylactically inhibit Varicella Zoster Virus (VZV) reactivation and reduce the incidence of Immunocompromised and Communicable Diseases.

Condition

Clinical Trials

Trial Phases

prophylaxis of HSV re-activation

0 Actively Recruiting

prophylaxis of VZV re-activation

0 Actively Recruiting

VZV re-activation

0 Actively Recruiting

Neutropenia

14 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Phase 4

Genital Herpes

0 Actively Recruiting

Encephalitis, Herpes Simplex

0 Actively Recruiting

Communicable Diseases

1 Actively Recruiting

Phase 3

Chickenpox

3 Actively Recruiting

Phase 2, Phase 1

Herpes Simplex Infections

0 Actively Recruiting

Keratitis, Herpetic

0 Actively Recruiting

Shingles

14 Actively Recruiting

Phase 4, Phase 2, Phase 3, Phase 1, Not Applicable

Cytomegalovirus Infections

6 Actively Recruiting

Phase 2, Phase 1, Not Applicable

Cytomegalovirus Infections

0 Actively Recruiting

Herpes simplex type I reactivation

0 Actively Recruiting

Bone Marrow Transplant

23 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 1

Immunocompromised

4 Actively Recruiting

Phase 3, Not Applicable, Phase 1

Herpes Labialis

0 Actively Recruiting

Genital Herpes

0 Actively Recruiting

Recurrent Herpes Labialis

1 Actively Recruiting

Phase 3

Bell's Palsy

0 Actively Recruiting

Sitavig Reviews: What are patients saying about Sitavig?

4.7Patient Review

7/21/2020

Sitavig for Cold Sore

This drug is on the pricey side, but it cleared my cold sore quickly and I haven't had one in over 18 months.

1.7Patient Review

2/10/2015

Sitavig for Cold Sore

Valtrex was more effective for me when taken at the first sign of a cold sore.

1Patient Review

6/7/2016

Sitavig for Cold Sore

This pill is way too expensive for how ineffective it is. I had to keep taking oral pills even after starting this treatment, and I tried it twice just to give it a chance. No dice.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about sitavig

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How much does Sitavig cost?

"The average retail price of Sitavig is $1,202.11, 23% off the average retail price of $1,202.11. Compare herpes virus nucleosides."

Answered by AI

How long does it take for Sitavig to dissolve?

"When the tablet is applied to the gums, it needs to stay there for 6 hours, but it may take up to 14 hours to dissolve."

Answered by AI

What is Sitavig used for?

"SITAVIG is a prescription medicine that is used to treat cold sores in adults who have normal immune systems."

Answered by AI

Is Sitavig covered by insurance?

"Your doctor can prescribe a drug called Sitavig. The cost of the drug depends on your insurance coverage, any prescription deductibles you have, and your prescription copay. There is a patient access card for Sitavig which may reduce the copay for qualifying patients."

Answered by AI

Clinical Trials for Sitavig

Image of Moffitt Cancer Center in Tampa, United States.

PATH for Bone Marrow Transplant

"This trial is studying how a positive psychology program called PATH can help improve anxiety, depression, and quality of life in people who have had a stem cell transplant, compared to standard care."

Waitlist Available

Moffitt Cancer Center (+2 Sites)Hermioni Amonoo, MD, MPP, MPH

Image of Geisinger Clinic in Danville, United States.

High risk + multi-fact for Shingles

This trial aims to see if sending messages to patients to ask about the Shingrix vaccine will help increase vaccination rates. They will also determine which message version works the best.

Geisinger ClinicChristopher F Chabris, PhD

Image of Ann & Robert H. Lurie Children's Hospital in Chicago, United States.

Recombinant Zoster Vaccine for Chickenpox

This trial will study the safety and effectiveness of a new vaccine in organ transplant recipients to prevent the virus that causes shingles.

Waitlist Available

Ann & Robert H. Lurie Children's HospitalRavi Jhaveri, MD

Image of Nationwide Children's Hospital in Columbus, United States.

CliniMACS® for Blood Cancers

"This trial is testing a new device called CliniMACS® Alpha-Beta T-cell/CD19 depletion for children and young adults with blood cancers who are having a stem cell transplant from a donor

Nationwide Children's Hospital

Have you considered Sitavig clinical trials? We made a collection of clinical trials featuring Sitavig, we think they might fit your search criteria.

Explore trials for Sitavig

Image of Canadian Center for Vaccinology in Halifax, Canada.

ChAdOx1-VZV Vaccine for Shingles

Halifax, Canada

This trial tests how safe and effective a new drug is by having participants take 2 doses over 4 months. Blood samples will be taken to evaluate results.

Canadian Center for VaccinologyScot Halperin, MDCanSino Biologics Inc.

Image of GSK Investigational Site in Daphne, United States.

RSV + Shingles Vaccines for Older Adults

This trial tests a possible vaccine combo in older adults to see if it can create an immune response and how safe it is.

Waitlist Available

GSK Investigational Site (+20 Sites)GlaxoSmithKline

Image of University of Michigan Rogel Cancer Center in Ann Arbor, United States.

Cardio-oncology Program for Bone Marrow Transplant Patients

This trial will test if a program can help cancer patients reduce the risk of cardiovascular events and improve their cardio-respiratory fitness.

University of Michigan Rogel Cancer CenterSalim Hayek

Image of Omeros Investigational Site in San Diego, United States.

Narsoplimab for Post-Transplant TMA

This trial studies how safe and effective a drug is for children who had a blood cell transplant and then had blood clots in tiny blood vessels.

Omeros Investigational Site (+7 Sites)Omeros Corporation

Have you considered Sitavig clinical trials? We made a collection of clinical trials featuring Sitavig, we think they might fit your search criteria.

Explore trials for Sitavig

Image of University of Colorado Hospital in Aurora, United States.

Shingrix Vaccine for Bone Marrow Transplant Recipients

This trial will determine if a vaccine against shingles is safe and effective in people who have had stem cell transplants.

University of Colorado HospitalMyron Levin, MDGlaxoSmithKline

Image of Proactive Clinical Research,LLC in Fort Lauderdale, United States.

RNA Vaccine for Shingles

Fort Lauderdale, FL

This trial studies the safety, side effects and immune response of a VZV modRNA vaccine in adults ages 50-69. Participants receive different doses and formulations, and may stay in the study for up to 5 years.

Proactive Clinical Research,LLC (+39 Sites)Pfizer CT.gov Call CenterPfizer

Image of Dana-Farber Cancer Institute in Boston, United States.

mRNA-1647 Vaccine for Cytomegalovirus Infection

This trial will study if a new drug (mRNA-1647) can help prevent a virus infection after a stem cell transplant.

Senior-friendly

Dana-Farber Cancer InstituteModernaTX, Inc.

Image of GSK Investigational Site in Jonesboro, United States.

Combined Measles-Mumps-Rubella-Chickenpox Vaccine for Children's Immunization

This trial will assess the safety and effectiveness of different strengths of a vaccine against measles, mumps, rubella, and chickenpox in healthy children aged 4-6.

GSK Investigational Site (+9 Sites)GSK Clinical TrialsGlaxoSmithKline

Have you considered Sitavig clinical trials? We made a collection of clinical trials featuring Sitavig, we think they might fit your search criteria.

Explore trials for Sitavig

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security